Genetic testing study for hard-to-classify bone marrow failure
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study looks for gene changes in families affected by rare inherited bone marrow failure that can cause fragile bones and fractures. It may help doctors understand the condition better by linking genetic mutations with family health patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed inherited bone marrow failure condition in your family (in two generations).
- Your family members have symptoms like fragile bones and fractures.
- You are able and willing to join family-wide genetic testing and consent to participate.
- You do not have paroxysmal nocturnal hemoglobinuria (a specific blood disorder).
- You do not have newly diagnosed (de novo) myelodysplastic syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patients with suspected inherited (families-linked) bone marrow failure to better understand the cause using genetic testing. It may help confirm a diagnosis and refine how different inherited conditions are classified.
This trial is a global survey and registry for people with Shwachman-Diamond Syndrome and related inherited blood disorders. It aims to connect patients, families, and researchers to better understand these conditions and improve care.
This study analyzes blood, bone marrow, and medical information from people with bone marrow failure syndromes (BMFS) and healthy volunteers to better understand these conditions and find new ways to help patients.
This study looks at why people with inherited bone marrow failure syndromes (rare genetic conditions affecting blood cell production) have higher cancer risk. Researchers want to understand the genetic and medical factors that increase cancer likelihood, which could help doctors monitor and protect affected patients and their families.
This study follows people who may have early, unclear blood count problems or certain genetic/immune patterns that can later lead to bone marrow failure or blood cancers. It may help doctors better understand risks over time and guide earlier care.
This study is a national registry that collects health information and some blood or tissue samples from people diagnosed with bone marrow failure. It helps researchers understand causes and long-term outcomes, and may improve care by building a large patient database.
Hear when a new Inherited BMF Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.